|
"tanwandee t"的相關文件
顯示項目 21-24 / 24 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2012-05-20 |
Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial
|
Poon, RTP;Chen, LT;Xue, HL;Tannir, B;Wang, JH;Tanwandee, T;Paik, SW |
| 高雄醫學大學 |
2011 |
Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.
|
莊萬龍; Patel K;Thompson AJ;Chuang WL;Lee CM;Peng CY;Shanmuganathan G;Thongsawat S;Tanwandee T;Mahachai V;Pramoolsinsap C;Cho M;Han KH;Shah SR;Foster GR;Clark PJ;Pulkstenis E;Subramanian GM;McHutchison JG. |
| 國立成功大學 |
2009-10 |
Long-term entecavir (ETV) therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in patients with HBeAg positive and negative chronic hepatitis B (CHB): results from studies ETV-022,-027 and-901
|
Chang, Ting-Tsung; Wu, S. S.; Chao, Y. C.; Han, K. H.; Yoon, S. K.; Lai, C. L.; Akbar, N.; Liaw, Y. F.; Tanwandee, T.; Goodman, Z. D.; Zhang, H.; Hindes, R.; Iloeje, U.; Beebe, S.; Kreter, B. |
| 國立成功大學 |
2009-10 |
Long-term entecavir therapy improves fibrosis/cirrhosis and results in continued histologic improvement in CHB
|
Chang, Ting-Tsung; Wu, S. S.; Chao, Y. C.; Han, K. H.; Yoon, S. K.; Lai, C. L.; Akbar, N.; Liaw, Y. F.; Tanwandee, T.; Munafo, L.; Newman, J.; Slade, P.; Goodman, Z. D.; Zhang, H.; Hindes, R.; Iloeje, U.; Beebe, S.; Kreter, B. |
顯示項目 21-24 / 24 (共1頁)
1
每頁顯示[10|25|50]項目
|
